You are here: Industry Insights > MIMETAS

News List

MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology PharmaSources
April 04, 2023
MIMETAS, a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company.
MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development b3cnewswire
July 07, 2021
MIMETAS announced today that they have entered into a collaboration to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV).
MIMETAS Opens Phenotypic Screening Center b3cnewswire
May 28, 2021
MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center.
MIMETAS to Launch Assay Ready Product Line for Organ-on-a-Chip prnasia
March 03, 2020
MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate® Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions against an extracellular matrix.
Mimetas Chairman of the Board Herbert Heyneker Receives Dutch Royal Honor b3cnewswire
September 23, 2019
Herbert ‘Herb’ Heyneker, Chairman of the Board of Directors at Mimetas and Dutch biotech pioneer, has been honored by the Dutch Monarchy for his contributions ...
Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology b3cnewswire
March 06, 2019
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules derived from human kidney adult stem cells in microfluidic chips. This research has been published in Nature Biotechnology by the world-l
MIMETAS collaborates with Roche to develop new chip technology biospectrumasia
August 21, 2017
MIMETAS works with Roche on new chip technology system which is designed to support intestinal permeability assessment.
Molecular Devices and MIMETAS Present New Turnkey Solution for Organ-On-A-Chip Market b3cnewswire
February 07, 2017
In a move to serve customers with ready-to-use solutions for organ-on-a-chip model development and analysis, MIMETAS and Molecular Devices will combine marketing efforts on the OrganoPlate® organ-on-a-chip platform and ImageXpress® Micro Confocal high-con